FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2900628081> ?p ?o ?g. }

• W2900628081 endingPage "382" @default.
• W2900628081 startingPage "371" @default.
• W2900628081 abstract "Objective To examine the association of commonly prescribed post-concussive medications, namely gabapentin and tricyclic antidepressants (TCAs), with symptom reduction after concussion. Background Concussion is a common diagnosis in modern medicine. Many providers use medication to target the residual symptoms of a concussion, with little evidence supporting their efficacy. Design Retrospective study with longitudinal analysis using mixed-effects and piecewise regression analyses of 277 patients presenting to an academic sports medicine clinic, all of whom were clinically diagnosed with a concussion. Main outcomes were patient-reported headache score (quantitative variable; 0–6) and combined symptom score (quantitative variable; 0–132) from the Post-Concussion Symptom Scale (PCSS). Methods Patients self-reported their symptom scores on the PCSS at the time of each clinic visit. Gabapentin or TCAs were prescribed to some patients during their follow-ups for headache treatment, based on physician judgment. Patients were classified into 3 groups: (1) no medication; (2) gabapentin; or (3) TCAs. Follow-up data were evaluated over 1 year. A mixed-effects and piecewise regression analysis were performed to assess long- and short-term effects of medication status. Results The mixed-effects analysis showed a significant decrease in both headache and symptom scores over time in each medication group and in those not receiving medication (P ≤ .014 for all scenarios, B = −0.005 and −0.08, respectively). Although patients in the 2 medication groups showed significantly higher headache and symptom scores (P < .001), neither medication had a significant effect on longitudinal improvements in the outcome scores. The piecewise regression, however, showed short-term improvements with gabapentin (1.3 points, P = .004) and more sustained improvements with TCAs (3.5 points, P = .006). Conclusions Patients recover from a concussion with time, regardless of medication. Gabapentin and TCAs appear to have immediate effects on improving symptom burden, but long-term outcomes show similar improvement compared to those who are not prescribed medication. More rigorous prospective studies are required to better elucidate their efficacy." @default.
• W2900628081 created "2018-11-29" @default.
• W2900628081 creator A5004211750 @default.
• W2900628081 creator A5024062035 @default.
• W2900628081 creator A5060792746 @default.
• W2900628081 creator A5063447692 @default.
• W2900628081 creator A5075684986 @default.
• W2900628081 creator A5084238679 @default.
• W2900628081 date "2018-11-19" @default.
• W2900628081 modified "2023-09-27" @default.
• W2900628081 title "Gabapentin and Tricyclics in the Treatment of Post‐Concussive Headache, a Retrospective Cohort Study" @default.
• W2900628081 cites W1964653093 @default.
• W2900628081 cites W1969968240 @default.
• W2900628081 cites W1970735673 @default.
• W2900628081 cites W1970941371 @default.
• W2900628081 cites W1981481796 @default.
• W2900628081 cites W1990514899 @default.
• W2900628081 cites W1991396892 @default.
• W2900628081 cites W2003912110 @default.
• W2900628081 cites W2011690556 @default.
• W2900628081 cites W2015351378 @default.
• W2900628081 cites W2054974318 @default.
• W2900628081 cites W2062926546 @default.
• W2900628081 cites W2073687865 @default.
• W2900628081 cites W2074202258 @default.
• W2900628081 cites W2077666750 @default.
• W2900628081 cites W2078530346 @default.
• W2900628081 cites W2092737999 @default.
• W2900628081 cites W2106213482 @default.
• W2900628081 cites W2116075855 @default.
• W2900628081 cites W2120093801 @default.
• W2900628081 cites W2135480846 @default.
• W2900628081 cites W2179806176 @default.
• W2900628081 cites W2226285065 @default.
• W2900628081 cites W2574839142 @default.
• W2900628081 cites W2801085490 @default.
• W2900628081 cites W3026969958 @default.
• W2900628081 cites W3192952715 @default.
• W2900628081 cites W4233399822 @default.
• W2900628081 cites W4235573432 @default.
• W2900628081 cites W4255246509 @default.
• W2900628081 doi "https://doi.org/10.1111/head.13451" @default.
• W2900628081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30451286" @default.
• W2900628081 hasPublicationYear "2018" @default.
• W2900628081 type Work @default.
• W2900628081 sameAs 2900628081 @default.
• W2900628081 citedByCount "19" @default.
• W2900628081 countsByYear W29006280812019 @default.
• W2900628081 countsByYear W29006280812020 @default.
• W2900628081 countsByYear W29006280812021 @default.
• W2900628081 countsByYear W29006280812022 @default.
• W2900628081 countsByYear W29006280812023 @default.
• W2900628081 crossrefType "journal-article" @default.
• W2900628081 hasAuthorship W2900628081A5004211750 @default.
• W2900628081 hasAuthorship W2900628081A5024062035 @default.
• W2900628081 hasAuthorship W2900628081A5060792746 @default.
• W2900628081 hasAuthorship W2900628081A5063447692 @default.
• W2900628081 hasAuthorship W2900628081A5075684986 @default.
• W2900628081 hasAuthorship W2900628081A5084238679 @default.
• W2900628081 hasConcept C126322002 @default.
• W2900628081 hasConcept C142724271 @default.
• W2900628081 hasConcept C167135981 @default.
• W2900628081 hasConcept C1862650 @default.
• W2900628081 hasConcept C187212893 @default.
• W2900628081 hasConcept C190385971 @default.
• W2900628081 hasConcept C194828623 @default.
• W2900628081 hasConcept C204787440 @default.
• W2900628081 hasConcept C2776608144 @default.
• W2900628081 hasConcept C2777177866 @default.
• W2900628081 hasConcept C2778426673 @default.
• W2900628081 hasConcept C3017944768 @default.
• W2900628081 hasConcept C71924100 @default.
• W2900628081 hasConcept C72563966 @default.
• W2900628081 hasConceptScore W2900628081C126322002 @default.
• W2900628081 hasConceptScore W2900628081C142724271 @default.
• W2900628081 hasConceptScore W2900628081C167135981 @default.
• W2900628081 hasConceptScore W2900628081C1862650 @default.
• W2900628081 hasConceptScore W2900628081C187212893 @default.
• W2900628081 hasConceptScore W2900628081C190385971 @default.
• W2900628081 hasConceptScore W2900628081C194828623 @default.
• W2900628081 hasConceptScore W2900628081C204787440 @default.
• W2900628081 hasConceptScore W2900628081C2776608144 @default.
• W2900628081 hasConceptScore W2900628081C2777177866 @default.
• W2900628081 hasConceptScore W2900628081C2778426673 @default.
• W2900628081 hasConceptScore W2900628081C3017944768 @default.
• W2900628081 hasConceptScore W2900628081C71924100 @default.
• W2900628081 hasConceptScore W2900628081C72563966 @default.
• W2900628081 hasIssue "3" @default.
• W2900628081 hasLocation W29006280811 @default.
• W2900628081 hasLocation W29006280812 @default.
• W2900628081 hasOpenAccess W2900628081 @default.
• W2900628081 hasPrimaryLocation W29006280811 @default.
• W2900628081 hasRelatedWork W2402398382 @default.
• W2900628081 hasRelatedWork W2521136782 @default.
• W2900628081 hasRelatedWork W2531547067 @default.
• W2900628081 hasRelatedWork W2538734629 @default.
• W2900628081 hasRelatedWork W2603773853 @default.
• W2900628081 hasRelatedWork W2900628081 @default.

• next